Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAPK3 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → MAPK3 |
| (<<) ALDOA → MAPK3 |
| (<<) CFL1 → MAPK3 |
| (<<) EFHD2 → MAPK3 |
| (<<) ELF4 → MAPK3 |
| (<<) FA2H → MAPK3 |
| (<<) PRKCD → MAPK3 |
| (<<) TSPO → MAPK3 |
| Downstream (Children) |
|---|
| MAPK3 → ADCY6 (>>) |
| MAPK3 → CASP4 (>>) |
| MAPK3 → CDR2 (>>) |
| MAPK3 → CHST12 (>>) |
| MAPK3 → CREB3L1 (>>) |
| MAPK3 → GNAI2 (>>) |
| MAPK3 → HMGCS1 (>>) |
| MAPK3 → IQSEC2 (>>) |
| MAPK3 → LRP3 (>>) |
| MAPK3 → MEX3D (>>) |
| MAPK3 → SHC1 (>>) |
| MAPK3 → SMURF1 (>>) |
